Literature DB >> 7014727

Bacterial adherence: adhesin-receptor interactions mediating the attachment of bacteria to mucosal surface.

E H Beachey.   

Abstract

Recent studies have indicated that the attachment of bacteria to mucosal surfaces is the initial event in the pathogenesis of most infectious diseases due to bacteria in animals and humans. An understanding of the mechanisms of attachment and a definition of the adhesive molecules on the surfaces of bacteria (adhesins) as well as those on host cell membranes (receptors) have suggested new approaches to the prevention of serious bacterial infections: (1) application of purified adhesion or receptor materials or their analogues as competitive inhibitors of bacterial adherence; (2) administration of sublethal concentrations of antibiotics that suppress the formation and expression of bacterial adhesins; and (3) development of vaccines against bacterial surface components involved in adhesion to mucosal surfaces. Progress has already been made in the development of antiadhesive vaccines directed against the fimbrial adhesins of several human bacterial pathogens.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7014727     DOI: 10.1093/infdis/143.3.325

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  384 in total

1.  Functional domains present in the mycobacterial hemagglutinin, HBHA.

Authors:  G Delogu; M J Brennan
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

2.  R1 region of P97 mediates adherence of Mycoplasma hyopneumoniae to swine cilia.

Authors:  F C Minion; C Adams; T Hsu
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

3.  Adherence of Burkholderia pseudomallei cells to cultured human epithelial cell lines is regulated by growth temperature.

Authors:  Nat F Brown; Justin A Boddey; Cameron P Flegg; Ifor R Beacham
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

4.  In vitro adhesion and platelet aggregation properties of bacteremia-associated lactobacilli.

Authors:  P V Kirjavainen; E M Tuomola; R G Crittenden; A C Ouwehand; D W Harty; L F Morris; H Rautelin; M J Playne; D C Donohue; S J Salminen
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Adhesion to and invasion of HEp-2 cells by Campylobacter spp.

Authors:  M E Konkel; L A Joens
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

6.  Effect of Tamm-Horsfall urinary glycoprotein on phagocytosis and killing of type I-fimbriated Escherichia coli.

Authors:  S M Kuriyama; F J Silverblatt
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

7.  Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors.

Authors:  S N Abraham; J P Babu; C S Giampapa; D L Hasty; W A Simpson; E H Beachey
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

8.  Globoside-specific adhesins of uropathogenic Escherichia coli are encoded by similar trans-complementable gene clusters.

Authors:  B Lund; F P Lindberg; M Båga; S Normark
Journal:  J Bacteriol       Date:  1985-06       Impact factor: 3.490

9.  A whole-organ perfusion model of Bordetella pertussis adherence to mouse tracheal epithelium.

Authors:  L O Bakaletz; M S Rheins
Journal:  In Vitro Cell Dev Biol       Date:  1985-06

10.  Antibodies that bind to fimbriae block adhesion of Streptococcus sanguis to saliva-coated hydroxyapatite.

Authors:  S Fachon-Kalweit; B L Elder; P Fives-Taylor
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.